J Clin Oncol 2022 Jun 21
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.
Related Questions
How do you balance the therapeutic efficacy of CN with long-term CKD risk from radical nephrectomy?
New answer by Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty (October 14, 2025)
Nephron-sparing strategies (partial nephrectomy or stereotactic radiation therapy are reserved for patients with limited disease, favorable anatomy, or contraindications to su...